← 返回

表面修饰对磁性纳米环在肝细胞癌和免疫细胞中分布的影响

英文原题:Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells.

查看英文原题

Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells.

PubMed 2024/03/06(内容时间) J Mater Chem B Q2 · IF 6.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

磁性纳米材料介导的磁热疗是一种局部加热治疗方式,已在临床上用于治疗侵袭性癌症。除了被肿瘤细胞摄取以发挥癌症治疗作用外,磁性纳米材料还可被肿瘤微环境中的免疫细胞内化,这可能有助于调节抗肿瘤免疫效应。

然而,关于磁性纳米材料在肿瘤组织内不同类型细胞中分布的研究很少。在此,成功合成了带有或不带有肝癌靶向肽SP94的亚铁磁性涡旋畴氧化铁纳米环(FVIOs)作为模型系统,以研究FVIOs表面修饰(带或不带SP94)对小鼠肝细胞癌(HCC)微环境中肿瘤细胞和不同免疫细胞分布的影响。FVIO-SP94s在肿瘤细胞中的分布比例是FVIOs的1.3倍。肝脏肿瘤微环境中的免疫细胞对FVIO-SP94s的摄取少于FVIOs。

此外,发现髓系细胞在吞噬纳米颗粒的能力方面比淋巴系细胞强得多。具体而言,FVIOs/FVIO-SP94s在肿瘤相关巨噬细胞、树突状细胞和髓源性抑制细胞中的分布分别为13.8%/12%、3.7%/0.9%和6.3%/1.2%。而FVIOs/FVIO-SP94s在T细胞、B细胞和NK 细胞中的分布分别为5.5%/0.7%、3.0%/0.7%和0.4%/0.3%。本文所述结果加深了我们对纳米材料在肿瘤微环境中分布的理解,并为合理设计能够有效调控抗肿瘤免疫效应的磁热疗剂提供了策略。

展开英文摘要原文

Magnetic nanomaterial-mediated magnetic hyperthermia is a localized heating treatment modality that has been applied to treat aggressive cancer in clinics.

In addition to being taken up by tumor cells to function in cancer therapy, magnetic nanomaterials can also be internalized by immune cells in the tumor microenvironment, which may contribute to regulating the anti-tumor immune effects.

However, there exists little studies on the distribution of magnetic nanomaterials in different types of cells within tumor tissue.

Herein, ferrimagnetic vortex-domain iron oxide nanorings (FVIOs) with or without the liver-cancer-targeting peptide SP94 have been successfully synthesized as a model system to investigate the effect of surface modification of FVIOs (with or without SP94) on the distribution of tumor cells and different immune cells in hepatocellular carcinoma (HCC) microenvironment of a mouse. The distribution ratio of FVIO-SP94s in tumor cells was 1. 3 times more than that of FVIOs. Immune cells in the liver tumor microenvironment took up fewer FVIO-SP94s than FVIOs.

In addition, myeloid cells were found to be much more amenable than lymphoid cells in terms of their ability to phagocytose nanoparticles. Specifically, the distributions of FVIOs/FVIO-SP94s in tumor-associated macrophages, dendritic cells, and myeloid-derived suppressor cells were 13. 8%/12%, 3. 7%/0. 9%, and 6. 3%/1. 2%, respectively.

While the distributions of FVIOs/FVIO-SP94s in T cells, B cells, and natural killer cells were 5. 5%/0. 7%, 3. 0%/0. 7%, and 0. 4%/0. 3%, respectively. The results described in this article enhance our understanding of the distribution of nanomaterials in the tumor microenvironment and provide a strategy for rational design of magnetic hyperthermia agents that can effectively regulate anti-tumor immune effects.

论文信息

作者
Jiao W、Wen N、Wang S、Zhou G、Lu Q、Su Z、Wang X、Hu S
第一作者单位
Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.China
通讯作者单位
National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. zhangnan930928@126.com.China
文献类型
非美国政府资助研究
期刊
Journal of materials chemistry. B2024 Mar 6
原文标识
PubMed 38376513 · DOI 10.1039/d3tb02560h